High Mark Wealth Management LLC Janux Therapeutics, Inc. Transaction History
High Mark Wealth Management LLC
- $217 Million
- Q3 2025
A detailed history of High Mark Wealth Management LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 265 shares of JANX stock, worth $7,555. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265Holding current value
$7,555% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding JANX
# of Institutions
188Shares Held
56MCall Options Held
869KPut Options Held
652K-
Ra Capital Management, L.P. Boston, MA11.2MShares$319 Million5.65% of portfolio
-
Janus Henderson Group PLC London, X04.46MShares$127 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.92MShares$83.3 Million3.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$72 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$66.8 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.19B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...